Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics

Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics Professional…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—April 28, 2026

This week’s Artificial Intelligence and Digital Health update highlights…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML

Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sun Pharma acquisition of Organon

Lucid Diligence Brief: Sun Pharma acquisition of Organon Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Regeneron Otarmeni FDA approval

Lucid Diligence Brief: Regeneron Otarmeni FDA approval Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Avalyn Pharma IPO

Lucid Diligence Brief: Avalyn Pharma IPO Professional audiences only. Not…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership

Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million financing

Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash

Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—April 20, 2026

This week’s Artificial Intelligence and Digital Health update highlights…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: 10x Genomics launches Atera Platform

Lucid Diligence Brief: 10x Genomics launches Atera Platform Professional…


Privacy Preference Center